The Food and Drug Administration (FDA) faces criticism for restricting access to 7-hydroxymitragynine (7-OH), a kratom-derived compound that offers relief from chronic pain and opioid withdrawal. The ...
Fair Observer’s Communications and Outreach officer, Roberta Campani, speaks with Nuno Guimarães, a professor of Computer Sciences at ISCTE-University Institute of Lisbon. They discuss the complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback